GlaxoSmithKline: all 4,196 studies
Page 23 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting ConditionsWithdrawnNCT04964050Phase 1
- Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)Active, not recruitingNCT04954859Phase 2
- An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.CompletedNCT04950712
- A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an ExtensionCompletedNCT04880031Phase 2
- Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting ConditionsWithdrawnNCT04878315Phase 1
- A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 YearsTerminatedNCT04762511Phase 1
- Low-dose Fostemsavir Extended Release Relative Bioavailability StudyCompletedNCT04757974Phase 1
- A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic DermatitisCompletedNCT04693195Phase 2
- Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughCompletedNCT04678206Phase 2
- A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active ComparatorCompletedNCT04525599Phase 1
- An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza InfectionCompletedNCT04494412Phase 2
- A Clinical Study to Assess Force Required to Dislodge Upper Denture With and Without Use of a Novel Denture AdhesiveWithdrawnNCT04473521Phase 3
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult ParticipantsTerminatedNCT04472897Phase 1
- Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid TumorsActive, not recruitingNCT04446351Phase 1
- A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic FunctionWithdrawnNCT04398680Phase 1
- A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic DermatitisCompletedNCT04271514Phase 1
- Single Ascending Dose of ASP3772 Study in Japanese Healthy Male and Female Adults, and Single Ascending Dose Study of ASP3772 in Comparison With PPSV23 in Japanese Elderly Male and Female SubjectsCompletedNCT04265911Phase 1
- Linerixibat Long-term Safety, and Tolerability StudyActive, not recruitingNCT04167358Phase 3
- Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's DiseaseWithdrawnNCT04151225Phase 2
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy AdultsCompletedNCT04062669Phase 1
- A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial CancerActive, not recruitingNCT03981796Phase 3
- Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in JapanCompletedNCT03957577
- Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness StudyWithdrawnNCT03949842Phase 4
- A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan AfricaCompletedNCT03855995
- Managed Access Program for Combination Treatment With Belantamab Mafodotin in Multiple MyelomaApproved for marketingNCT03763370
- A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic AsthmaWithdrawnNCT03707678Phase 2
- Pooled Analysis of Clinical Data From Six GSK Studies to Investigate the Efficacy of a Dentifrice Containing 67% Weight by Weight (w/w) Sodium Bicarbonate on Gingivitis and Plaque AccumulationCompletedNCT03703245
- Compassionate Use Individual Request Program for GSK525762 in NUT Midline CarcinomaNo longer availableNCT03702036
- Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1aWithdrawnNCT03697824Phase 2
- BLU-5937: First-in-Human, Single and Multiple Doses Escalation, Safety, Tolerability, Pharmacokinetics and Food EffectCompletedNCT03638180Phase 1
- Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World SettingCompletedNCT03595930
- Pro-arrhythmic Potential of GSK3039294 in Healthy SubjectsWithdrawnNCT03567499Phase 1
- BOTOX® Drug Use Investigation (Spasmodic Dysphonia)Status unknownNCT03543150
- Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP)CompletedNCT03501420
- Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment DecisionsCompletedNCT03465332
- Extended Access of Momelotinib in Adults With MyelofibrosisActive, not recruitingNCT03441113Phase 2
- Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03436511
- Real-world Insights of People With Human Immunodeficiency Virus (HIV) InfectionCompletedNCT03400293
- Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS)CompletedNCT03399461
- Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled AsthmaWithdrawnNCT03376932Phase 3
- The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on AsthmaWithdrawnNCT03363191Phase 4
- A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin HypersensitivityWithdrawnNCT03361774Phase 2
- Patient-Reported Outcome Measurement Information System (PROMIS) Physical FunctionCompletedNCT03351140
- A Study to Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With AsthmaCompletedNCT03344406
- Perceptions of Cell and Gene Therapies (CGT) for the Treatment of CancerCompletedNCT03336567
- A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting ConditionsWithdrawnNCT03329547Phase 1
- PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)CompletedNCT03327740
- Phase 4 Study of Dolutegravir (DTG) in Russian FederationCompletedNCT03314064Phase 4
- Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With MenCompletedNCT03310515
- Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) SubjectsCompletedNCT03304548
- Subject Insights to Understand Rheumatoid Arthritis (RA)CompletedNCT03285191
- Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological StudyCompletedNCT03271593
- Subject Insights to Understand the Hand Osteoarthritis (HOA)CompletedNCT03271203
- A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid TumorsWithdrawnNCT03266159Phase 2
- Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT03243760Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)WithdrawnNCT03239600Phase 2
- RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term)CompletedNCT03219255
- GSK2894512 Vehicle-Controlled Study for Adult Plaque PsoriasisWithdrawnNCT03202004Phase 3
- A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult SubjectsWithdrawnNCT03201978Phase 1
- A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese ChildrenWithdrawnNCT03192371Phase 4
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated MothersWithdrawnNCT03191383Phase 2
- Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, ColombiaTerminatedNCT03188458Phase 4
- Arnuity® Ellipta® Drug Use InvestigationCompletedNCT03184480
- Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in IsraelWithdrawnNCT03183492Phase 4
- Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03170999
- Patient Characteristics and Treatment Modalities in COPD Patients in ChinaCompletedNCT03161587
- Study of Subjects With Diabetic Foot Ulcer (DFU)CompletedNCT03153007
- The Extended Salford Lung Study ("Ex-SLS") Data Access ProjectCompletedNCT03152669
- Prevalence of Severe Asthma in Spanish HospitalsCompletedNCT03137043
- Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung DiseaseCompletedNCT03136120
- Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian InfantsWithdrawnNCT03128489Phase 3
- Compassionate Use for Subcutaneous (SC) BelimumabNo longer availableNCT03125486
- A Physiological Profile of Recovery From Resistance, Endurance, and Mixed Exercise TypesCompletedNCT03083509Not applicable
- FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference SurveyCompletedNCT03046069
- A Cross-sectional Study on COPD PrevalenceCompletedNCT03028207
- Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian CancerApproved for marketingNCT03025867
- Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care PatientsCompletedNCT03018808
- A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes MellitusWithdrawnNCT03015519Phase 3
- A 7-year Assessment on Subject Understanding of ZYBAN/ WELLBUTRIN Associated RisksCompletedNCT03001440
- A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese ChildrenCompletedNCT02991872Phase 4
- Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy SubjectsCompletedNCT02972905Phase 1
- Phase 1 Study of GSK2315698 in Healthy Japanese SubjectsCompletedNCT02953808Phase 1
- A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus PlaceboCompletedNCT02948881Phase 4
- Pharmacokinetics of Single and Repeat Oral Doses of Trametinib in Chinese Subjects With Solid TumoursWithdrawnNCT02939846Phase 1
- A Phase I Study to Assess the Pharmacokinetics of GSK2798745 TabletsCompletedNCT02925546Phase 1
- Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia RheumaticaWithdrawnNCT02899026Phase 3
- Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible TabletCompletedNCT02893488Phase 1
- A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy SubjectsCompletedNCT02859259Phase 1
- A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.CompletedNCT02839135Phase 1
- A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese SubjectsCompletedNCT02837380Phase 1
- Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult ParticipantsCompletedNCT02832362Phase 1
- A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Active, not recruitingNCT02817633Phase 1
- Absolute Bioavailability of BMS-626529 After Oral and Intravenous DosingCompletedNCT02805556Phase 1
- Dose-escalation Study of GSK2330672 in Japanese Healthy Male VolunteersCompletedNCT02801981Phase 1
- A Study to Evaluate the Effect of High Fat Meal on CabotegravirCompletedNCT02799264Phase 1
- A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal SubjectsCompletedNCT02798991Phase 1
- A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer SubjectsCompletedNCT02797977Phase 1/2
- Single and Repeated Dose Escalation Study of GSK2838232CompletedNCT02795754Phase 1
- A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled AsthmaWithdrawnNCT02794519Phase 2
- Placebo-controlled Proof of Concept Study of Epelsiban in Women With AdenomyosisWithdrawnNCT02794467Phase 2